A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

ABC has claimed that Ingo Rademacher's argument that Steve Burton's rehiring was not new evidence and has no bearing on his ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

ABC asked a judge to shut down fired General Hospital star Ingo Rademacher’s plea for a trial against the network, months ...

Recent health news highlights various developments, including EssilorLuxottica's FDA clearance for Nuance audio glasses, WHO ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...

South Carolina Governor race has no candidates but it hasn't stopped Congresswoman Nancy Mace from relentlessly attacking ...

The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.